{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35501396",
  "DateCompleted": {
    "Year": "2022",
    "Month": "08",
    "Day": "19"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "09",
    "Day": "18"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "05",
        "Day": "02"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1038/s41576-022-00478-5"
    ],
    "Journal": {
      "ISSN": "1471-0064",
      "JournalIssue": {
        "Volume": "23",
        "Issue": "9",
        "PubDate": {
          "Year": "2022",
          "Month": "Sep"
        }
      },
      "Title": "Nature reviews. Genetics",
      "ISOAbbreviation": "Nat Rev Genet"
    },
    "ArticleTitle": "The human genetic epidemiology of COVID-19.",
    "Pagination": {
      "StartPage": "533",
      "EndPage": "546",
      "MedlinePgn": "533-546"
    },
    "Abstract": {
      "AbstractText": [
        "Human genetics can inform the biology and epidemiology of coronavirus disease 2019 (COVID-19) by pinpointing causal mechanisms that explain why some individuals become more severely affected by the disease upon infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus. Large-scale genetic association studies, encompassing both rare and common genetic variants, have used different study designs and multiple disease phenotype definitions to identify several genomic regions associated with COVID-19. Along with a multitude of follow-up studies, these findings have increased our understanding of disease aetiology and provided routes for management of COVID-19. Important emergent opportunities include the clinical translatability of genetic risk prediction, the repurposing of existing drugs, exploration of variable host effects of different viral strains, study of inter-individual variability in vaccination response and understanding the long-term consequences of SARS-CoV-2 infection. Beyond the current pandemic, these transferrable opportunities are likely to affect the study of many infectious diseases."
      ],
      "CopyrightInformation": "\u00a9 2022. Springer Nature Limited."
    },
    "AuthorList": [
      {
        "Identifier": [
          "0000-0003-0696-6175"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland."
          }
        ],
        "LastName": "Niemi",
        "ForeName": "Mari E K",
        "Initials": "MEK"
      },
      {
        "Identifier": [
          "0000-0002-0949-8752"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland."
          },
          {
            "Identifier": [],
            "Affiliation": "Broad Institute, Cambridge, MA, USA."
          },
          {
            "Identifier": [],
            "Affiliation": "Analytical and Translational Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA."
          }
        ],
        "LastName": "Daly",
        "ForeName": "Mark J",
        "Initials": "MJ"
      },
      {
        "Identifier": [
          "0000-0002-8147-240X"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland. andrea.ganna@helsinki.fi."
          },
          {
            "Identifier": [],
            "Affiliation": "Broad Institute, Cambridge, MA, USA. andrea.ganna@helsinki.fi."
          },
          {
            "Identifier": [],
            "Affiliation": "Analytical and Translational Genetics Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. andrea.ganna@helsinki.fi."
          }
        ],
        "LastName": "Ganna",
        "ForeName": "Andrea",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Nat Rev Genet",
    "NlmUniqueID": "100962779",
    "ISSNLinking": "1471-0056"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [
        "epidemiology",
        "genetics"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Epidemiology"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Pandemics"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    }
  ],
  "CoiStatement": "M.E.K.N. is an employee of Novartis. M.J.D. and A.G. declare no competing interests."
}